Top Markets
Coin of the day
Almirall, S.A. Almirall, S.A.

Almirall, S.A.

ALM
Ранг среди акций #5431
Almirall, S.A. is a biopharmaceutical firm dedicated to the discovery,... Almirall, S.A. is a biopharmaceutical firm dedicated to the discovery, development, production, and commercialization of treatments primarily focused on skin health. Operating globally, with a significant presence in Europe and the United States, its product line targets various dermatological ailments such as actinic keratosis, atopic dermatitis, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, and acne, alongside rare skin conditions. Beyond its core dermatology focus, the company also offers solutions for cardiovascular, musculoskeletal, respiratory, and nervous system disorders, as well as products for digestive health, anti-infectives for systemic use, genitourinary conditions and sex hormones, immunostimulants, and systemic hormonal preparations. Its extensive portfolio includes a range of well-known medications, such as Ilumetri, Solaraze, Skilarence, and Klisyri, among others. Almirall fosters strategic partnerships with numerous entities to advance its pipeline, including research institutions like the University of Dundee and commercial partners such as Eli Lilly and Company. Founded in Barcelona, Spain, in 1943, the company adopted its current name, Almirall, S.A., in May 2009, having previously been known as Laboratorios Almirall, S.A.
Цена акции
$12.43
Рыночная капитализация
$2.71B
Изменение (1 день)
-0.19%
Изменение (1 год)
-4.33%
Страна
ES
Торговля Almirall, S.A. (ALM)

Категория

EPS для Almirall, S.A. (ALM)
EPS по состоянию на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Almirall, S.A., текущий EPS компании (TTM) составляет 0. В конце 2026 EPS компании составлял 0, равна показателю 2026 года, равному 0.
История EPS компании Almirall, S.A. с 2026 по 2026
EPS на конец каждого года
Год EPS Изменить
Недостаточно данных для указанных дат.
EPS для аналогичных компаний или конкурентов